LABZ — Metasphere Labs Income Statement
0.000.00%
- CA$3.39m
- CA$3.10m
- CA$2.20m
Annual income statement for Metasphere Labs, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | R2022 July 31st | 2023 July 31st | 2024 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 7.01 | 0.655 | 2.2 |
Cost of Revenue | |||||
Gross Profit | — | — | 6.28 | 0.545 | 1.84 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.06 | 0.053 | 19.7 | 13 | 2.22 |
Operating Profit | -0.06 | -0.053 | -12.7 | -12.4 | -0.02 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.06 | -0.053 | -12.9 | -12.4 | -0.014 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.06 | -0.053 | -11.7 | -12.4 | -0.014 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.06 | -0.053 | -12.1 | -12.5 | -0.014 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.06 | -0.053 | -12.1 | -12.5 | -0.014 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.043 | -0.036 | -6.36 | -3.06 | 0.027 |